Rigel Pharmaceuticals Company Profile (NASDAQ:RIGL)

Analyst Ratings

Consensus Ratings for Rigel Pharmaceuticals (NASDAQ:RIGL) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.25 (220.80% upside)

Analysts' Ratings History for Rigel Pharmaceuticals (NASDAQ:RIGL)
Show:
DateFirmActionRatingPrice TargetActions
7/13/2016HC WainwrightInitiated CoverageBuy$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016Piper Jaffray Cos.Initiated CoverageOverweight$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Jefferies GroupReiterated RatingBuy$10.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/23/2016Credit Suisse Group AGUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/22/2016JPMorgan Chase & Co.UpgradeNeutral -> Overweight$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2015Wells Fargo & Co.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Rigel Pharmaceuticals (NASDAQ:RIGL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/3/2016Q116($0.19)($0.19)$4.00 million$5.03 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q415($0.14)($0.14)$8.90 million$8.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315($0.17)($0.08)$5.00 million$12.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215($0.22)($0.16)$2.67 million$5.18 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q414($0.18)($0.21)$16.00 million$2.18 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2015Q4($0.27)($0.25)$2.50 million$8.25 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314($0.27)($0.24)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214($0.25)($0.29)$1.05 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114($0.25)($0.25)$0.43 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2014Q4 13($0.25)($0.19)$5.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313($0.29)($0.27)$260.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013Q2 2013($0.30)($0.26)$0.53 million$1.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2013Q1 2013($0.30)($0.29)$1.73 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/5/2013Q4 2012($0.32)($0.30)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2012Q312($0.38)($0.36)$0.84 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012($0.34)($0.35)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012($0.33)($0.32)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2012($0.28)($0.36)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011($0.28)($0.25)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011($0.36)($0.37)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011($0.36)($0.40)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Rigel Pharmaceuticals (NASDAQ:RIGL)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.17)($0.17)($0.17)
Q2 20161($0.18)($0.18)($0.18)
Q3 20161($0.17)($0.17)($0.17)
Q4 20161$0.41$0.41$0.41
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Rigel Pharmaceuticals (NASDAQ:RIGL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Rigel Pharmaceuticals (NASDAQ:RIGL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
4/1/2015Donald G PayanEVPSell10,000$3.75$37,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/18/2014Dolly VanceEVPSell1,000$2.22$2,220.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014Donald G PayanEVPSell20,000$2.56$51,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2013Bvf Partners P/Ilmajor shareholderSell484,622$2.64$1,279,402.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2013Bvf Partners L P/IlMajor ShareholderBuy32,700$3.47$113,469.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2012Dolly VanceEVPSell4,151$10.43$43,294.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Rigel Pharmaceuticals (NASDAQ:RIGL)
DateHeadline
07/23/16 09:58 AMOption Market: Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Risk Hits An Extreme High - CML News
07/23/16 09:58 AMRigel Pharmaceuticals Inc. (RIGL) is Trading Lower on Unusual Volume for July 21 - Equities.com
07/22/16 09:05 AMRigel Pharmaceuticals Inc Stock Technicals at Critical Inflection Point - CML News
07/22/16 09:05 AMLatest Analysts Score of Stocks: Teva Pharmaceutical Industries Limited (NYSE:TEVA) , Rigel Pharmaceuticals, Inc ... - Street Updates
07/22/16 09:05 AMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Current Analyst Ratings - Fiscal Standard
07/21/16 08:58 AMStock Moving Lower for the Month; Investor Update on Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Engelwood Daily
07/19/16 07:06 AMWhy You Should Own Rigel Pharmaceuticals, Inc. - Seeking Alpha
07/18/16 01:14 PMETF’s with exposure to Rigel Pharmaceuticals, Inc. : July 18, 2016 -
07/18/16 11:40 AMStrong Sell Calls For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) At 0 - Investor Newswire
07/16/16 05:36 PMWere Analysts Bullish Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) This Week? - Press Telegraph
07/16/16 09:23 AMShares Experiencing a Downtrend: Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - TGP
07/16/16 09:23 AMBroker Outlook For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Fiscal Standard
07/16/16 09:23 AMRigel Pharmaceuticals Inc Realized Volatility Hits an Inflection Level - CML News
07/15/16 11:21 AMShare Volatility Watch for: Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Engelwood Daily
07/15/16 11:21 AMRigel Pharmaceuticals, Inc. Has Another Very Weak Trading Session - Consumer Eagle
07/14/16 09:46 AMThis Week In Pharma: What Can We Expect From Rigel's And Ultragenyx's Upcoming Phase 3 Results?
07/13/16 09:15 AMSoaring +11% In Pre-Market, Rigel Receives Buy Initiation Amid Fostamatinib Phase 3 Optimism - The first Phase 3 trials for Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL)'s Syk inhibitor are expected to be announced in August as many investors and analysts prepare for the results. H.C. Wrainwright's Positive Take On Phase 3 H.C. Wainwright & Co's Shaunak Deepak initiated Rigel Pharmaceuticals at Buy with a price target of $6.00. "We believe fosta (Fostamamtinib) is likely to show a significant benefit over placebo, due to a historically low placebo-response rate in ITP (0–5 percent)," stated Deepak. Additionally, positive data from the phase 2 study supports the probable success of the phase 3 study according to the ...Full story available on Benzinga.com
07/13/16 09:01 AMH.C. Wainwright Starts Coverage on Rigel Pharmaceuticals, Inc. (RIGL) With A Rating Of “Buy”
07/12/16 06:22 PMRigel Pharmaceuticals Inc Stock Momentum at Critical Inflection Point - CML News
07/12/16 10:32 AMRigel Pharmaceuticals Incorporated (NASDAQ:RIGL) Sellers Covered 5.35% of Their Shorts - Consumer Eagle
07/09/16 05:30 PMIs $10 Within Reach For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)? - Investor Newswire
07/07/16 06:11 PMOption Market: Rigel Pharmaceuticals Inc. Risk Hits An Extreme High - CML News
07/07/16 06:11 PMRigel Pharmaceuticals Inc (NASDAQ:RIGL): Positive Stock Sentiment - Engelwood Daily
07/06/16 10:47 AMCould Rigel Pharmaceuticals, Inc. See a Reversal After This Very Strong Session? - Press Telegraph
07/05/16 10:35 AMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Broker Price Targets For The Coming Week - Fiscal Standard
07/03/16 10:17 AMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Expected to Reach Highs Of $10 - Investor Newswire
07/01/16 06:09 PMAre Analysts Bullish Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) After Last Week? - Engelwood Daily
06/30/16 08:57 AMToday Rigel Pharmaceuticals, Inc. Stock Crashes - Engelwood Daily
06/28/16 06:02 PMRigel Pharmaceuticals Incorporated (NASDAQ:RIGL) Short Interest Decreased By 5.35% - Engelwood Daily
06/27/16 10:18 AMNext Weeks Broker Price Targets For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Fiscal Standard
06/25/16 05:34 PMStrong Sell Calls Recommendations For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) At 0 - Investor Newswire
06/25/16 09:51 AMRigel Pharmaceuticals Inc. (RIGL) Jumps 5.56% on June 23 - Equities.com
06/24/16 08:44 AMRigel Pharmaceuticals Incorporated (NASDAQ:RIGL) Shorted Shares Increased By 1.39% - Press Telegraph
06/23/16 08:46 AMRigel Pharmaceuticals Inc. (RIGL) is Trading Higher on Unusual Volume for June 20 - Equities.com
06/22/16 10:52 AMRigel Pharmaceuticals Inc. (RIGL) is Trading Higher on Unusual Volume for June 20
06/18/16 10:16 AMRigel Pharmaceuticals Inc. (RIGL) is Trading Higher on Unusual Volume for June 16 - Equities.com
06/13/16 05:44 AMCoverage initiated on Rigel Pharma by Piper Jaffray -
06/02/16 06:35 PMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). The latest reports which are currently in issue on Thursday 2nd of June state 0 analysts have a rating of “strong buy”, 0 ...Rigel to Present at Jefferies 2016 Healthcare ConferenceSatellite PR News (press release)all 2 news articles »
06/02/16 06:35 AMRigel to Present at Jefferies 2016 Healthcare Conference - [at noodls] - SOUTH SAN FRANCISCO, Calif., June 2, 2016 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Ryan Maynard, the company's chief financial officer, is scheduled to present a ...
06/01/16 09:02 AMRigel Pharmaceuticals Inc. (RIGL) is Trading Lower on Unusual Volume for May 30 - Equities.com - Rigel Pharmaceuticals Inc. (RIGL) is Trading Lower on Unusual Volume for May 30Equities.comRigel Pharmaceuticals Inc. (RIGL) experienced unusually high volume on May. 30, as the stock lost 1.2% to a closing price of $2.46. The stock saw 634,469 shares trade hands over the course of the day on 1,704 trades. Given that the stock's average ...and more »
05/31/16 10:32 AMStrong Sell Calls Count For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) At 0 - Investor Newswire - Strong Sell Calls Count For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) At 0Investor NewswireRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has a total of 2 Strong Buy calls and 0 Strong Sell advises as of 2016-05-30. Zacks uses a rating procedure which assigns scores to stocks on a narrow 1-5 scale. When a stock gets a score of 1 or 2, it is ...and more »
05/31/16 10:32 AMWhat's Ahead for Rigel Pharma (RIGL): A Look Back at Recent Q&A - Equities.com - Equities.comWhat's Ahead for Rigel Pharma (RIGL): A Look Back at Recent Q&AEquities.comI was reading the transcript from the March 2016 Earnings call (see below)..and thought it would be a good time to reach out and get some feedback from Raul Rodriguez, Rigel Pharmaceuticals - CEO as to where they are to date. I like the company who ...
05/25/16 12:05 PMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Closes At $2.49 - Investor Newswire - Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Closes At $2.49Investor NewswireYesterday, the stock of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) closed at $2.49 after opening at $2.49 and registering high of $2.57 and low of $2.49. The last price is $-1.21 off 1-year high of $3.78 and $0.69 away from low of $1.88 during same period.
05/21/16 11:56 AMRigel Pharmaceuticals Incorporated (NASDAQ:RIGL) Shorted Shares Decreased By 2.09% - Wall Street Hints and News - Rigel Pharmaceuticals Incorporated (NASDAQ:RIGL) Shorted Shares Decreased By 2.09%Wall Street Hints and NewsThe short interest to Rigel Pharmaceuticals Incorporated's float is 2.53%. The stock increased 3.32% or $0.08 on May 20, hitting $2.49. About 169,569 shares traded hands. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has declined 16.44% since October 15, ...
05/19/16 06:54 PMETF’s with exposure to Rigel Pharmaceuticals, Inc. : May 19, 2016 -
05/19/16 11:57 AMRigel Pharmaceuticals Inc. (RIGL) is Trading Lower on Unusual Volume for May 17 - Equities.com - Rigel Pharmaceuticals Inc. (RIGL) is Trading Lower on Unusual Volume for May 17Equities.comRigel Pharmaceuticals Inc. (RIGL) experienced unusually high volume on May. 17, as the stock lost 0.83% to a closing price of $2.39. The stock saw 876,390 shares trade hands over the course of the day on 2,966 trades. Given that the stock's average ...Snapshot of Recent Traded Stocks: Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) , Radius Health, Inc. (NASDAQ:RDUS)Street Updatesall 2 news articles »
05/18/16 12:41 PMRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Hovering Around $2.30 - Investor Newswire - Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Hovering Around $2.30Investor NewswireOn performing technical analysis of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stock, it is noted that the stock is $-0.17 points away -6.65% from its fifty-day MA of $2.50. It is $-0.38 or -13.95% away $2.71, the 200-day MA (Moving Average) of stock ...Next Weeks Broker Price Targets For Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Share Trading NewsRigel Pharmaceuticals Incorporated (NASDAQ:RIGL) Sellers Covered 2.09% of Their ShortsWall Street Hints and NewsJefferies Holds To Rating And Lowers Price Target On Rigel Pharmaceuticals, Inc. (RIGL)Finance Dailyall 6 news articles »
05/17/16 02:54 PMRigel Pharmaceuticals, Inc. :RIGL-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/10/16 12:04 PMRIGEL PHARMACEUTICALS INC Financials -
05/03/16 04:32 PMRIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and -

Social

About Rigel Pharmaceuticals

Rigel Pharmaceuticals logoRigel Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company discovers and develops small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disorders. Its research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. It has various product candidates in development: fostamatinib; R348; two oncology product candidates, and two preclinical programs. Fostamatinib is an oral spleen tyrosine kinase (SYK) inhibitor. R348 is a topical janus kinase (JAK)/SYK inhibitor. It is conducting research in the disease areas of inflammation/immunology and muscle wasting/muscle endurance.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: RIGL
  • CUSIP: 76655960
Key Metrics:
  • Previous Close: $2.23
  • 50 Day Moving Average: $2.31
  • 200 Day Moving Average: $2.45
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $208.25M
  • Beta: 1.24
  • Current Year EPS Consensus Estimate: $-0.58 EPS
  • Next Year EPS Consensus Estimate: $-0.76 EPS
Additional Links:
Rigel Pharmaceuticals (NASDAQ:RIGL) Chart for Saturday, July, 23, 2016